From Our Partners
Monday, July 4, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

New BSL 3 Lab Improves Canadian Biodefense Capabilities

by Global Biodefense Staff
September 24, 2012

A highly sophisticated Biosafety Level 3 (BSL 3) containment laboratory at the Saskatchewan Disease Control Laboratory (SDCL) officially began operations earlier this month.

The SDCL provides a range of services for regional public health institutions including testing for and monitoring of: environmental specimens, food-borne illnesses, communicable diseases, and influenza. The laboratory also supports the biosafety and biohazard spill response programs for the province.

The new BSL 3 lab provides a safe and secure environment for handling dangerous microbes such as tuberculosis, anthrax, tularemia, and pandemic influenza, as well as newly emerging diseases.

“This new lab’s improved testing capability and faster intervention will allow us to do a broader range of testing in-province for a number of diseases – and will prove very significant in the event of a public health crisis such as SARS or another influenza pandemic,” stated Health Minister Dustin Duncan.

The BSL 3 lab received required certifications over the summer by the Public Health Agency of Canada and the Canadian Food Inspection Agency.  SDCL is located at Innovation Place, adjacent to the University of Regina. The state-of-the-art facility opened in 2010.

Source: Government of Saskatchewan

From Our Partners
Tags: AnthraxBiosafety

Related Posts

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps
Outbreak News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC